Breaking News Instant updates and real-time market news.

13:55
01/29/20
01/29
13:55
01/29/20
13:55

House Financial Services Committee to hold a hearing

The Subcommittee on Housing, Community Development & Insurance holds a hearing entitled, "Examining the Availability of Insurance for Nonprofits" on January 29 at 2 pm. Webcast Link

TODAY'S FREE FLY STORIES

Upgrade
TC Energy upgraded to Neutral from Sell at Goldman Sachs » 18:25
02/23/20
02/23
18:25
02/23/20
18:25
TRP

TC Energy

$57.39 /

+0.05 (+0.09%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Enbridge downgraded to Sell from Neutral at Goldman Sachs » 18:23
02/23/20
02/23
18:23
02/23/20
18:23
ENB

Enbridge

$41.87 /

+0.115 (+0.28%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

On The Fly
Box Office Battle: 'Sonic the Hedgehog' wins weekend again with $26.5M » 17:14
02/23/20
02/23
17:14
02/23/20
17:14
T

AT&T

$38.54 /

-0.075 (-0.19%)

, CMCSA

Comcast

$45.81 /

-0.21 (-0.46%)

, CMCSK

Comcast

$0.00 /

+ (+0.00%)

, SNE

Sony

$65.92 /

-0.78 (-1.17%)

, LGF.A

Lionsgate

$10.01 /

-0.25 (-2.44%)

, LGF.B

Lionsgate

$9.40 /

-0.24 (-2.49%)

, DIS

Disney

$138.93 /

-1.42 (-1.01%)

, VIACA

ViacomCBS

$32.82 /

-0.895 (-2.65%)

, VIAC

ViacomCBS

$28.26 /

-1.03 (-3.52%)

ViacomCBS (VIAC)…

Open Full Text

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Envestnet return profile just improved following correction, says Jefferies » 16:47
02/23/20
02/23
16:47
02/23/20
16:47
ENV

Envestnet

$78.97 /

-7.43 (-8.60%)

Jefferies analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
Boeing to offer more support for Max suppliers, WSJ reports » 16:19
02/23/20
02/23
16:19
02/23/20
16:19
BA

Boeing

$330.39 /

-5.885 (-1.75%)

, EADSY

Airbus

$0.00 /

+ (+0.00%)

Boeing (BA) is planning…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
Amazon in Holocaust row about 'Hunters' series, Reuters reports » 16:16
02/23/20
02/23
16:16
02/23/20
16:16
AMZN

Amazon.com

$2,094.29 /

-58.64 (-2.72%)

The Auschwitz Memorial…

The Auschwitz Memorial criticized Amazon for fictitious depictions of the Holocaust in its Prime series "Hunters" and for selling books of Nazi propaganda, according to Reuters. "Hunters" features a team of Nazi hunters in 1970s New York who discover that hundreds of escaped Nazis are living in the U.S., the report notes. However, the series has faced accusations of bad taste, particularly for depicting fictional atrocities in Nazi death camps. Reference Link

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
French Minister says no global digital tax deal would mean chaos,Reuters reports » 16:11
02/23/20
02/23
16:11
02/23/20
16:11
GOOG

Alphabet

$1,484.27 /

-33.78 (-2.23%)

, GOOGL

Alphabet Class A

$1,482.84 /

-33.7 (-2.22%)

, FB

Facebook

$210.11 /

-4.43 (-2.06%)

, AMZN

Amazon.com

$2,094.29 /

-58.64 (-2.72%)

France's Finance…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Kadmon announces expanded results of interim analysis of KD025 trial in cGVHD » 16:05
02/23/20
02/23
16:05
02/23/20
16:05
KDMN

Kadmon

$5.08 /

+0.03 (+0.59%)

Kadmon announced expanded…

Kadmon announced expanded results from the previously reported interim analysis of ROCKstar, its ongoing pivotal trial of KD025 in chronic graft-versus-host disease. As announced in November 2019, KD025 met the primary endpoint of Overall Response Rate at the study's planned interim analysis, two months after completion of enrollment. KD025 showed statistically significant and clinically meaningful ORRs of 64% with KD025 200 mg once daily and 67% with KD025 200 mg twice daily. In the expanded KD025-213 dataset presented, ORRs were consistent with the previously reported interim analysis across key subgroups, including in patients with four or more organs affected by cGVHD, patients who had prior treatment with ibrutinib and patients who had prior treatment with ruxolitinib. Three patients achieved a Complete Response. Responses were observed in all affected organ systems, including in organs with fibrotic disease. KD025 has been well tolerated: adverse events were consistent overall with those expected to be observed in cGVHD patients receiving corticosteroids, and no apparent increased risk of infection was observed. Additional secondary endpoints, including duration of response, corticosteroid dose reductions, Failure-Free Survival, Overall Survival and Lee Symptom Scale reductions continue to mature and will be available later in 2020. At the TCT Meetings, Kadmon also presented long-term follow-up data from KD025-208, its ongoing Phase 2 study of KD025 in cGVHD. These data were recently presented at the 61st American Society of Hematology Annual Meeting and Exposition in December 2019.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Spherix announces special dividend distribution » 16:02
02/23/20
02/23
16:02
02/23/20
16:02
HOTH

Hoth Therapeutics

$4.41 /

+ (+0.00%)

, SPEX

Spherix

$1.03 /

+0.015 (+1.49%)

Spherix (SPEX) announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
Intuit near deal to buy Credit Karma for $7B in cash and stock, WSJ reports » 09:58
02/23/20
02/23
09:58
02/23/20
09:58
INTU

Intuit

$297.77 /

-3.47 (-1.15%)

Intuit is nearing a deal…

Intuit is nearing a deal to buy Credit Karma for about $7B in cash and stock, Wall Street Journal's Cara Lombardo and Dana Cimilluca report, citing people familiar with the matter. The maker of TurboTax could announce a deal to buy privately held Credit Karma by Monday, assuming talks don't fall apart, the people said. Credit Karma was valued at roughly $4B in a private share sale about two years ago, the authors note. Reference Link

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
Volkswagen to face first U.S. jury trial, Bloomberg reports » 07:29
02/23/20
02/23
07:29
02/23/20
07:29
VWAGY

Volkswagen

$0.00 /

+ (+0.00%)

Volkswagen faces a new…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
Twitter suspends group of pro-Bloomberg accounts over manipulation, Reuters says » 07:26
02/23/20
02/23
07:26
02/23/20
07:26
TWTR

Twitter

$38.31 /

-0.73 (-1.87%)

Twitter said it had…

Twitter said it had started suspending and restricting dozens of accounts posting content promoting U.S. Democratic presidential candidate Michael Bloomberg, Reuters' Elizabeth Culliford writes. "We took enforcement action on about 70 accounts, which includes a combination of permanent suspensions and account challenges to verify ownership," a Twitter spokeswoman said in a statement to Reuters. Reference Link

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
Boeing finds debris inside 737 Max fuel tanks, Reuters reports » 07:24
02/23/20
02/23
07:24
02/23/20
07:24
BA

Boeing

$330.39 /

-5.885 (-1.75%)

Boeing has confirmed it…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
The ASTCT and CIBMTR to hold a joint meeting » 04:55
02/23/20
02/23
04:55
02/23/20
04:55
ABBV

AbbVie

$94.96 /

+0.7 (+0.74%)

, ADPT

Adaptive Biotechnologies

$34.19 /

+0.37 (+1.09%)

, AMGN

Amgen

$222.80 /

+0.62 (+0.28%)

, ATNM

Actinium Pharmaceuticals

$0.26 /

+0.0088 (+3.50%)

, ATRA

Atara Biotherapeutics

$13.18 /

-0.34 (-2.51%)

, AZN

AstraZeneca

$50.17 /

+1.2 (+2.45%)

, BLUE

Bluebird Bio

$80.15 /

-2.38 (-2.88%)

, CDNA

CareDx

$28.25 /

+0.13 (+0.46%)

, CDTX

Cidara Therapeutics

$3.16 /

+ (+0.00%)

, CELG

Bought by BMY

$0.00 /

+ (+0.00%)

, EQ

Equillium

$5.48 /

+0.38 (+7.45%)

, GMDA

Gamida Cell

$4.55 /

-0.2 (-4.21%)

, GSK

GlaxoSmithKline

$43.11 /

+0.35 (+0.82%)

, HUM

Humana

$369.65 /

-1.9 (-0.51%)

, INCY

Incyte

$80.89 /

-1.88 (-2.27%)

, JAZ

Jazz Technologies

$0.00 /

+ (+0.00%)

, KDMN

Kadmon

$5.08 /

+0.03 (+0.59%)

, MGTA

Magenta Therapeutics

$14.00 /

-0.02 (-0.14%)

, MRK

Merck

$82.34 /

-0.14 (-0.17%)

, NVS

Novartis

$96.75 /

+0.44 (+0.46%)

, PFE

Pfizer

$35.71 /

-0.13 (-0.36%)

, RCKT

Rocket Pharmaceuticals

$22.73 /

-1.01 (-4.25%)

, SGEN

Seattle Genetics

$117.00 /

-1.3 (-1.10%)

, SNY

Sanofi

$50.83 /

+0.07 (+0.14%)

, TAK

Takeda Pharmaceutical

$18.78 /

+0.195 (+1.05%)

American Society for…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Buffett 'almost certain' stocks will beat bonds if current rates, taxes hold » 14:21
02/22/20
02/22
14:21
02/22/20
14:21
BRK.B

Berkshire Hathaway

$229.25 /

+1.015 (+0.44%)

, BRK.A

Berkshire Hathaway

$343,750.00 /

+1326 (+0.39%)

, SPY

SPDR S&P 500 ETF Trust

$333.48 /

-3.49 (-1.04%)

, SPX

S&P 500

$0.00 /

+ (+0.00%)

Warren Buffet said in his…

Warren Buffet said in his annual letter to shareholders, "What we can say is that if something close to current rates should prevail over the coming decades and if corporate tax rates also remain near the low level businesses now enjoy, it is almost certain that equities will over time perform far better than long-term, fixed-rate debt instruments."

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Buffett's Berkshire spent $5B buying back own shares in 2019 » 14:19
02/22/20
02/22
14:19
02/22/20
14:19
BRK.B

Berkshire Hathaway

$229.25 /

+1.015 (+0.44%)

, BRK.A

Berkshire Hathaway

$343,750.00 /

+1326 (+0.39%)

Warren Buffet said in his…

Warren Buffet said in his annual letter to shareholders, "In past reports, we've discussed both the sense and nonsense of stock repurchases. Our thinking, boiled down: Berkshire will buy back its stock only if a) Charlie and I believe that it is selling for less than it is worth and b) the company, upon completing the repurchase, is left with ample cash. Calculations of intrinsic value are far from precise. Consequently, neither of us feels any urgency to buy an estimated $1 of value for a very real 95 cents. In 2019, the Berkshire price/value equation was modestly favorable at times, and we spent $5 billion in repurchasing about 1% of the company. Over time, we want Berkshire's share count to go down. If the price-to-value discount (as we estimate it) widens, we will likely become more aggressive in purchasing shares. We will not, however, prop the stock at any level."

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Buffett says Berkshire '100% prepared' for his, Munger's departure » 14:17
02/22/20
02/22
14:17
02/22/20
14:17
BRK.B

Berkshire Hathaway

$229.25 /

+1.015 (+0.44%)

, BRK.A

Berkshire Hathaway

$343,750.00 /

+1326 (+0.39%)

Warren Buffet said in his…

Warren Buffet said in his annual letter to shareholders, "Charlie and I long ago entered the urgent zone. That's not exactly great news for us. But Berkshire shareholders need not worry: Your company is 100% prepared for our departure. The two of us base our optimism upon five factors. First, Berkshire's assets are deployed in an extraordinary variety of wholly or partly-owned businesses that, averaged out, earn attractive returns on the capital they use. Second, Berkshire's positioning of its "controlled" businesses within a single entity endows it with some important and enduring economic advantages. Third, Berkshire's financial affairs will unfailingly be managed in a manner allowing the company to withstand external shocks of an extreme nature. Fourth, we possess skilled and devoted top managers for whom running Berkshire is far more than simply having a high-paying and/or prestigious job. Finally, Berkshire's directors - your guardians - are constantly focused on both the welfare of owners and the nurturing of a culture that is rare among giant corporations...Today, my will specifically directs its executors - as well as the trustees who will succeed them in administering my estate after the will is closed - not to sell any Berkshire shares. My will also absolves both the executors and the trustees from liability for maintaining what obviously will be an extreme concentration of assets."

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Berkshire Hathaway reports Q4 net earnings $4.42B vs. $5.72B last year » 14:06
02/22/20
02/22
14:06
02/22/20
14:06
BRK.B

Berkshire Hathaway

$229.25 /

+1.015 (+0.44%)

, BRK.A

Berkshire Hathaway

$343,750.00 /

+1326 (+0.39%)

At December 31, 2019,…

At December 31, 2019, Berkshire's insurance float was approximately $129B, an increase of $6B since year-end 2018.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
CommScope downgraded to Hold from Buy at Deutsche Bank » 14:02
02/22/20
02/22
14:02
02/22/20
14:02
COMM

CommScope

$12.62 /

+0.07 (+0.56%)

Deutsche Bank analyst…

Deutsche Bank analyst Vijay Bhagavath downgraded CommScope to Hold from Buy citing expected 2020 volatility following the company's Q4 results.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
Warren Buffet right to scarf up Kroger stock, Barron's says » 10:24
02/22/20
02/22
10:24
02/22/20
10:24
KR

Kroger

$30.31 /

+0.53 (+1.78%)

, WMT

Walmart

$118.58 /

+0.86 (+0.73%)

, BRK.A

Berkshire Hathaway

$343,750.00 /

+1326 (+0.39%)

, BRK.B

Berkshire Hathaway

$229.25 /

+1.015 (+0.44%)

Warren Buffett's…

Warren Buffett's Berkshire Hathaway (BRK.B) recently paid $549M for a 2.3% stake in Kroger (KR) as the chain grows digital sales by 21% year over year, Jack Hough writes in this week's edition of Barron's. Kroger goes for less than 13 times projected earnings, a 45% discount to Walmart (WMT), the author notes, adding, however, that both companies are expected to increase earnings per share by 4% to 6% during the year through January 2021. And Kroger stands to benefit indirectly as traditional supermarket shoppers migrate to Walmart.com, he contends. Reference Link

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
Virgin Galactic stock outperformance 'just hype,' Barron's says » 10:19
02/22/20
02/22
10:19
02/22/20
10:19
SPCE

Virgin Galactic

$33.70 /

-3.49 (-9.38%)

The latest frenzy…

The latest frenzy infecting stocks may be Virgin Galactic, which could very well be the "frothiest stock around right now," Tae Kim writes in this week's edition of Barron's. But even if Virgin Galactic does actually launch a commercial space-tourism business, its market dominance is not assured, the author notes. Noting that Investors need to assess Virgin Galactic's risks, given rising competitive threats, high expectations for space tourism, and a spotty record for meeting deadlines, Kim says the current stock price may look "pretty irrational." Reference Link

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
Caterpillar stock looks cheap, Barron's says » 07:32
02/22/20
02/22
07:32
02/22/20
07:32
CAT

Caterpillar

$137.25 /

+0.325 (+0.24%)

Caterpillar stock has…

Caterpillar stock has dipped to $137 from $150 at the start of this year, while the broad U.S. market has nudged a few percent higher, Jack Hough writes in this week's edition of Barron's. While the author acknowledges that fewer than half of analysts who cover the stock recommend buying it, Hough tells investors to consider doing so just the same. This year's earnings could mark a near-term trough for Caterpillar, while the stock's current valuation implies that U.S. economy is about to slip into recession, which seems unlikely, he argues. Reference Link

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
Intelsat could be 'a casualty' in brewing 5G showdown, Barron's says » 07:29
02/22/20
02/22
07:29
02/22/20
07:29
I

Intelsat

$4.50 /

-0.03 (-0.66%)

Intelsat's stock…

Intelsat's stock could again become a casualty in a 5G showdown among hedge-fund managers, satellite operators, and the federal government, Alexandra Scaggs writes in this week's edition of Barron's. The company's satellites transmit television signals over the so-called C-band, which is considered to be prime for fifth-generation, or 5G, service, with regulators wanting to clear out 60% of it for use by wireless companies, the authors note. A consortium of satellite operators called the C-Band Alliance volunteered to sell the spectrum privately in a plan that could have brought Intelsat as much as $24B, but the problem is that a private sale would require the Federal Communications Commission to give satellite operators the ability to sell rights they do not currently have, in the regulator's view, the author adds. Reference Link

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

On The Fly
Week in Review: How Trump's policies moved stocks » 07:19
02/22/20
02/22
07:19
02/22/20
07:19
GE

General Electric

$12.24 /

-0.285 (-2.28%)

, HON

Honeywell

$179.90 /

-0.78 (-0.43%)

, AMAT

Applied Materials

$64.27 /

-2.15 (-3.24%)

, LRCX

Lam Research

$316.74 /

-11.65 (-3.55%)

, MU

Micron

$56.98 /

-2.03 (-3.44%)

, WDC

Western Digital

$67.00 /

-2.04 (-2.95%)

, LITE

Lumentum

$83.21 /

-3.13 (-3.63%)

, ACIA

Acacia Communications

$68.69 /

-0.07 (-0.10%)

, NPTN

NeoPhotonics

$7.20 /

-0.31 (-4.13%)

, IIVI

II-VI

$34.73 /

-2.39 (-6.44%)

, ANTM

Anthem

$294.81 /

+0.48 (+0.16%)

, CNC

Centene

$65.41 /

-0.33 (-0.50%)

, CVS

CVS Health

$71.53 /

-0.42 (-0.58%)

, HUM

Humana

$369.65 /

-1.9 (-0.51%)

, MOH

Molina Healthcare

$149.82 /

-0.72 (-0.48%)

, UNH

UnitedHealth

$301.26 /

-0.705 (-0.23%)

, CUDA

Barracuda

$0.00 /

+ (+0.00%)

, CHKP

Check Point

$116.32 /

-1.21 (-1.03%)

, FFIV

F5 Networks

$133.38 /

+0.49 (+0.37%)

, FEYE

FireEye

$15.49 /

-0.19 (-1.21%)

, FTNT

Fortinet

$114.41 /

-3.62 (-3.07%)

, IMPV

Imperva

$0.00 /

+ (+0.00%)

, PANW

Palo Alto Networks

$242.86 /

-6.24 (-2.51%)

, PFPT

Proofpoint

$123.84 /

-1.97 (-1.57%)

, QLYS

Qualys

$91.49 /

-2.8 (-2.97%)

Catch up on the top…

Open Full Text

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
The ASTCT and CIBMTR to hold a joint meeting » 04:55
02/22/20
02/22
04:55
02/22/20
04:55
ABBV

AbbVie

$94.96 /

+0.7 (+0.74%)

, ADPT

Adaptive Biotechnologies

$34.19 /

+0.37 (+1.09%)

, AMGN

Amgen

$222.80 /

+0.62 (+0.28%)

, ATNM

Actinium Pharmaceuticals

$0.26 /

+0.0088 (+3.50%)

, ATRA

Atara Biotherapeutics

$13.18 /

-0.34 (-2.51%)

, AZN

AstraZeneca

$50.17 /

+1.2 (+2.45%)

, BLUE

Bluebird Bio

$80.15 /

-2.38 (-2.88%)

, CDNA

CareDx

$28.25 /

+0.13 (+0.46%)

, CDTX

Cidara Therapeutics

$3.16 /

+ (+0.00%)

, CELG

Bought by BMY

$0.00 /

+ (+0.00%)

, EQ

Equillium

$5.48 /

+0.38 (+7.45%)

, GMDA

Gamida Cell

$4.55 /

-0.2 (-4.21%)

, GSK

GlaxoSmithKline

$43.11 /

+0.35 (+0.82%)

, HUM

Humana

$369.65 /

-1.9 (-0.51%)

, INCY

Incyte

$80.89 /

-1.88 (-2.27%)

, JAZ

Jazz Technologies

$0.00 /

+ (+0.00%)

, KDMN

Kadmon

$5.08 /

+0.03 (+0.59%)

, MGTA

Magenta Therapeutics

$14.00 /

-0.02 (-0.14%)

, MRK

Merck

$82.34 /

-0.14 (-0.17%)

, NVS

Novartis

$96.75 /

+0.44 (+0.46%)

, PFE

Pfizer

$35.71 /

-0.13 (-0.36%)

, RCKT

Rocket Pharmaceuticals

$22.73 /

-1.01 (-4.25%)

, SGEN

Seattle Genetics

$117.00 /

-1.3 (-1.10%)

, SNY

Sanofi

$50.83 /

+0.07 (+0.14%)

, TAK

Takeda Pharmaceutical

$18.78 /

+0.195 (+1.05%)

American Society for…

American Society for Transplantation & Cellular Therapy (ASTCT) and the Center for International Blood & Marrow Transplant Research (CIBMTR) hold the 2020 TCT: Transplantation & Cellular Therapy Meeting will be held in Orlando on February 19-23.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.